4//SEC Filing
Lenz Robert A. 4
Accession 0001610717-23-000286
CIK 0001885522other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 5:58 PM ET
Size
7.1 KB
Accession
0001610717-23-000286
Insider Transaction Report
Form 4
Lenz Robert A.
Head of R&D
Transactions
- Award
Stock Option (Right to Buy)
2023-09-14+502,934→ 502,934 totalExercise: $17.00Exp: 2033-09-13→ Common Stock (502,934 underlying) - Award
Common Stock
2023-09-14+352,941→ 352,941 total
Footnotes (2)
- [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on September 11 of each year, with the first 1/4th vesting on September 11, 2024.
- [F2]25% of the shares subject to the option vest on the first anniversary measured from September 11, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
Neumora Therapeutics, Inc.
CIK 0001885522
Entity typeother
Related Parties
1- filerCIK 0001992908
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 5:58 PM ET
- Size
- 7.1 KB